AB CLINICAL RESEARCH LIMITED
Opportunity 80/100 (exceptional), bankability 75/100. Strong seller-intent signal (70/100, director aged 63). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Average employees | 100 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
Corporate timeline (18 events)Click to expand
- 2025-09-03📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-09-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-09-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-08-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-09-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-06-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-05-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-09-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2016-12-13📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2016-09-26📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-12-22📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-09-18📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2014-12-22📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-07-15📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2005-12-06🏢Company incorporatedAs AB CLINICAL RESEARCH LIMITED
- 2005-12-06➕BUSWELL, Anthony Paul appointedsecretary
- 2005-12-06➕BUSWELL, Allison Jane appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Long-tenure founder: Senior director has been in place 20 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 63 — approaching natural succession window.
- +No director turnover: Company is 20 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- primary20+ year tenure: Director in role 20 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 20 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Allison Buswell Individual · British · DOB 09/1963 · age 63 | 75–100% | — | 75-100% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Trade services · LE postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 77 LANDSCAPING LIMITED→ 11534652 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| 777 THAI MASSAGE THERAPY LTD→ 14322861 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 7MILES MARKETING LTD→ 15584187 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| A B LAWNCARE LTD→ 08573076 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| A BROCKLEHURST LIMITED→ 09047712 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| A&A CARPENTER DECORATOR LTD→ 15153086 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| A1 ACE TRANSPORT SERVICES LTD.→ 06466115 · est 2008 · no financials extracted | — | — | — | — | 18y | — | — |
| A71 TECHNICAL SERVICES LTD→ 14121155 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AADYA AESTHETICS LTD→ 15488546 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AAGM LTD→ 10554940 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| AARON SKIPPER STUDIO LIMITED→ 10191339 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AB COMPUTER SERVICES LTD→ 10239476 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.